Since the original description of the disorder by Anderson (1898) and Fabry (1898) the concept of this condition has gradually evolved from a purely dermatological curiosity to a generalized systemic disorder, shown by Scriba (1950) to be the result of an abnormality of lipid metabolism. Sweeley and Klionsky (1963) and Jensen (1966) established the disease specifically as a disorder of glycolipid metabolism and Brady et al (1967) identified it as an inborn error of metabolism caused by the absence of ceramide trihexosidase, an enzyme later shown to be a specific a-galactosidase (Kint, 1970) . Deficiency of this enzyme leads to intracellular accumulation throughout the body of ceramide trihexoside, and blood vessels are particularly affected; cardiovascular and renal disease are usually the terminal event in the fourth and fifth decades of life. Wallace (1973) has recently reviewed this disease comprehensively. He emphasized that early diagnosis was necessary to allow timely genetic advice.
The purpose of this study is to describe an unusual, previously unreported, family with Anderson-Fabry's disease in the north-east of England in which one member had a 47,XYY chromosome complement.
Methods
All members of the family with Anderson-Fabry's disease were clinically examined and had full ophthalmological assessment. Skin lesions were studied histo- 
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logically and bone marrow and rectal wall biopsies were done in the three living brothers with the disease. Full chromosome analysis by leucocyte culture using banding techniques was carried out on the three surviving affected brothers. Several lysosomal enzymes were assayed in the plasma and white cells of 3 living brothers using the appropriate 4-methylumbelliferyl substrate.
The method is described in Table I .
The family
The family tree comprising 4 generations and 36 subjects is shown in Fig. 1 . Four brothers in generation IV have been affected by Anderson-Fabry's disease. Good circumstantial evidence suggests that their mother (III.13 FM) had a mild form of the syndrome. Five other members of the family had signs and symptoms of familial spastic paraplegia. Members III.1, III.10, III.12, and III.13 died paraplegic. In these subjects weakness of the legs started after the second decade and progressed slowly but relentlessly. Ataxia was a prominent feature of III.13 FM and was also noted in the maternal grandmother (II.5 LP). The case histories of the members with Anderson-Fabry's disease are given below and IV.6, GM, a representative patient, is described in detail.
Case IV.6 (GM D/B 26. H. 1930) . GM, the eldest brother, had an unremarkable development until the age of 5 when he began to complain bitterly of pains in his legs and feet. Later his arms and hands were also affected, particularly the knuckles. On occasions he would complain of a vague persisting pain in his mouth.
Exercise, such as walking home from school could precipitate an attack of pain and the child often returned home crying. Hot weather was particularly unbearable. Assays were stopped by the addition of 0.3 M glycine/NaOH pH 10.6 to a final volume of 3 ml. The free methylumbelliferone was measured using a Perkin-Elmer fluorimeter. Excitation at 360 mz emission at 450 m".
It was soon realized that his ability to sweat was impaired and by early adolescence his ankles and legs began to swell. As he grew older the attacks of pain became less frequent and the severity of pain eased. He was first seen and diagnosed in September 1963. He was tall with long slender arms and fingers, prominent thick lips, and myopia. There was pitting oedema of both ankles extending half-way up the legs. His cardiovascular and respiratory systems were normal. Blood pressure was 130/80 mmHg. Skin examination showed crops of extensive, small angiokeratomata ( Fig.  2) on his lower lip, thighs, flanks, buttocks, scrotum, and penis. Investigations showed a normal haemoglobin, white cell count, and platelets. LE cells were not seen. Serum cholesterol was 5.05 mmol/l (195 mg/100 ml). Plasma urea was 3.5 mmol/l (21 mg/100 ml). There was proteinuria. An intravenous pyelogram was normal. A skeletal survey revealed bilateral cervical ribs, a bifid 7th cervical vertebra, and partial fusion of C2 with C3 and C6 with C7. Electromyography and electroencephalography were normal.
Review in 1967 confirmed the presence of proteinuria but the plasma urea remained normal at 3.5 mmol/l (21 mg/ 100 ml). Rectal wall biopsy and sternal marrow ( Fig. 3) showed large lipid-laden foam cells consistent with the diagnosis of Anderson-Fabry's disease. Hydroxyproline excretion was normal.
Further review in April 1974 showed no deterioration in renal function. Proteinuria persisted but his plasma creatinine was 106 Mumolfl (1.2 mg/100 ml) and plasma urea was 3.5 mmol/l (21 mg/100 ml). In April 1975, at the age of 45, the patient sustained an anterior myocardial infarct.
Case IV.7 (LM D/B 21.12.1933). LM, the second brother, developed normally but unlike the other three brothers his ankle and leg pains were not particularly troublesome. When first reviewed in 1967, his physique was similar to that of his brothers, with fleshy thick lips and long slender arms. Investigations showed no proteinuria, and the plasma urea was normal. Sternal marrow and rectal wall biopsy showed typical changes of Anderson-Fabry's disease with lipid-laden foam cells. Cutaneous angiokeratomata were present on his buttocks, lower trunk, scrotum, and elbows. Pitting oedema was present around both ankles. In 1974 proteinuria was detected but plasma urea was again normal at 3 mmol/l (18 mg/100 ml). (Fig. 5) with infiltration of the endothelium and smooth muscle by a doubly refractile glycolipid, easily demonstrable by polarized light (Fig. 6a and 6b ). Histology of rectal wall confirmed similar changes with glycolipid infiltration of the smooth muscle also affecting the walls of blood vessels.
Discussion
Clinical features. During the past few years several comprehensive reviews have described the mode of development, natural history, and symptomatology of Anderson-Fabry's disease (Wise, Wallace, and Jellinek, 1962; Carton, 1972; Wallace, 1973) . The affected brothers in this family exemplify most of the features of this rare disease. Painful cramps, usually the earliest presenting complaints, were present before the age of 11 in all brothers, and oedema of the ankles, hypohidrosis, cutaneous angiokeratomata, and proteinuria followed later. Thrombotic episodes developed in two of the patients. IV.6 GM developed a myocardial infarct at the age of 45 and IV.8 WM had a transient hemiparesis at the age of 32. Respiratory infections are particularly common in our family. In particular IV.8 WM has asthma which is occasionally troublesome. Similar respiratory findings have been described in other families (Bagdade et al, 1968 ) and Fabry's original patient had asthma, frequent respiratory infections, and eventually died of his pulmonary disease. Unlike other reported families (Wise et al, 1962) , the members of our family did not show any structural abnormalities of the urinary tract. Proteinuria was, however, present in all affected members. Cutaneous changes, initially the mainstay of clinical diagnosis, were found in all our patients. As previously reported in other families (Wallace, 1973) there was a variable incidence of angiokeratomata in the members of our family. IV.6 GM has extensive crops on most parts of the body (Fig. 2) , while IV.8 WM had only a few crops restricted to the buttocks. Hamburger et al (1964) and Clarke et al (1971) have described patients with AndersonFabry's disease and renal involvement in the absence of cutaneous angiokeratomata. Angiokeratomata have been found in patients with storage disorders other than Anderson-Fabry's disease. The typical cutaneous changes have been seen in patients with ,B-galactosidase deficiency and normal a-galactosidase levels (Loonen, Van der Lugt, and Franke, 1974; Wenger, Goodman, and Myers, 1974) and also in fucosidosis patients (Gatti et al, 1973; Kousseff et al, 1973) .
Inheritance. Inheritance in Anderson-Fabry's disease is X-linked (Opitz et al, 1965) but some heterozygous female carriers demonstrate mild clinical signs, in particular early corneal dystrophic changes, which can be of diagnostic importance. In this family there is evidence to suggest that the mother (III.13 FM) had a mild form of the disease. It is unfortunate that all four brothers (Fig. 1 (Desnick et al, 1972; Philippart, Franklin, and Gordon, 1972; Clarke et al, 1972; Biihler et al, 1973) . Apart from the aimed benefit from improved renal function, attempts at renal transplantation were also seriously pursued because of possible general improvement following the production by the transplanted kidney of the deficient a-galactosidase enzyme. Desnick et al (1972) and Philippart et al (1972) were able to show a rise in plasma a-galactosidase activity and a fall in ceramide trihexoside after successful renal transplantation. One of their patients reported return of near-normal sweating habits and relief from musculoskeletal pains. Clarke et al (1972) were not, however, able to reproduce the above good results, and in particular the sustained fall of plasma ceramide trihexoside. It is doubtful whether early prophylactic renal transplantation in the absence of end-stage renal failure is advisable or justifiable in view of the variable time it takes for renal failure to develop in this disease after the appearance of proteinuria and the morbidity and definite mortality that still accompany this procedure.
Diagnosis. The diagnosis of Anderson-Fabry's disease is easy when all features are present but in the absence of cutaneous changes or before these appear early diagnosis may be difficult. A high ESR and episodes of pyrexia may lead to the mistaken diagnosis of a collagen vascular disease and the administration of corticosteroids, the detrimental effects of which were clearly shown by the youngest of the four brothers who died grossly cushingoid at the age of 22. The diagnosis can now be confirmed biochemically by measuring ac-galactosidase activity. This enzyme can be measured in plasma and white blood cells using the artificial substrate 4-methylbumbelliferyl-a-Dgalactopyranoside, and is of particular value in suspected patients where cutaneous changes are not present. A further useful investigation is to look for corneal dystrophic changes. These are found at a very young age in patients with Anderson-Fabry's disease and are also present in carriers. The diagnosis can also be confirmed histologically by examination of sternal marrow (Fig. 3) 
